FDA Guidance Could Help Standardize Eligibility Criteria For Lung Cancer Trials

Clinical Research News | For patients with lung cancer, meeting the eligibility criteria for clinical trials has been a major roadblock to their participation. Over time, studies have grown more complex and expensive and sponsors, eager to optimize the scientific yield of a trial, have become incredibly strict about who meets the enrollment requirements.